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We aimed to estimate the clinical effectiveness of Community Occupational Therapy for
people with dementia and family carers–UK version (Community Occupational Therapy in
Dementia–UK version [COTiD-UK]) relative to treatment as usual (TAU). We hypothesised
that COTiD-UK would improve the ability of people with dementia to perform activities of
daily living (ADL), and family carers’ sense of competence, compared with TAU.
Methods and findings
The study design was a multicentre, 2-arm, parallel-group, assessor-masked, individu-
ally randomised controlled trial (RCT) with internal pilot. It was conducted in 15 sites
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across England from September 2014 to January 2018. People with a diagnosis of mild
to moderate dementia living in their own home were recruited in pairs with a family carer
who provided domestic or personal support for at least 4 hours per week. Pairs were ran-
domised to either receive COTiD-UK, which comprised 10 hours of occupational therapy
delivered over 10 weeks in the person with dementia’s home or TAU, which comprised
the usual local service provision that may or may not include standard occupational ther-
apy. The primary outcome was the Bristol Activities of Daily Living Scale (BADLS) score
at 26 weeks. Secondary outcomes for the person with dementia included the following:
the BADLS scores at 52 and 78 weeks, cognition, quality of life, and mood; and for the
family carer: sense of competence and mood; plus the number of social contacts and lei-
sure activities for both partners. Participants were analysed by treatment allocated. A
total of 468 pairs were recruited: people with dementia ranged from 55 to 97 years with a
mean age of 78.6 and family carers ranged from 29 to 94 with a mean of 69.1 years. Of
the people with dementia, 74.8% were married and 19.2% lived alone. Of the family car-
ers, 72.6% were spouses, and 22.2% were adult children. On randomisation, 249 pairs
were assigned to COTiD-UK (62% people with dementia and 23% carers were male)
and 219 to TAU (52% people with dementia and 32% carers were male). At the 26
weeks follow-up, data were available for 364 pairs (77.8%). The BADLS score at 26
weeks did not differ significantly between groups (adjusted mean difference estimate
0.35, 95% CI −0.81 to 1.51; p = 0.55). Secondary outcomes did not differ between the
groups. In total, 91% of the activity-based goals set by the pairs taking part in the
COTiD-UK intervention were fully or partially achieved by the final COTiD-UK session.
Study limitations include the following: Intervention fidelity was moderate but varied
across and within sites, and the reliance on primarily proxy data focused on measuring
the level of functional or cognitive impairment which may not truly reflect the actual per-
formance and views of the person living with dementia.
Conclusions
Providing community occupational therapy as delivered in this study did not improve
ADL performance, cognition, quality of life, or mood in people with dementia nor sense
of competence or mood in family carers. Future research should consider measuring
person-centred outcomes that are more meaningful and closely aligned to participants’
priorities, such as goal achievement or the quantity and quality of activity engagement
and participation.
Trial Registration
Current Controlled Trials ISRCTN10748953.
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Author summary
Why was this study done?
• Maintaining everyday and pleasurable activities can be difficult for a person with
dementia, as well as their family carer who often feels increasingly stressed as they need
to give more and more support.
• Occupational therapists assist people to improve their health and well-being through
carrying on with the activities they need and want to do. It is therefore important to
develop effective strategies to deliver occupational therapy to people with dementia and
their family carers who support them.
What did the researchers do and find?
• We tested the effectiveness of the Community Occupational Therapy in Dementia–UK
version (COTiD-UK) programme compared to the care that people with mild to moder-
ate dementia and their family carers usually receive, through a clinical trial.
• We recruited 468 pairs comprising a person with dementia and a family carer across
England who were randomly allocated to either take part in the COTiD-UK programme
or to continue with their usual care.
• We found no statistical evidence that COTiD-UK gave more benefit to people with
dementia or their carers than the usual care provided in terms of the people with
dementia being able to carry out activities or their mood or quality of life nor their fam-
ily carers’ sense of competence or mood.
• The pairs who took part in the COTiD-UK intervention set an average of 4.09 goals
each, of which 91% were fully or partially achieved by the final COTiD-UK session.
What do these findings mean?
• We did not find evidence to support commissioning the COTiD-UK intervention for
people with mild to moderate dementia and their family carers.
• Future studies need to develop more realistic methods of measuring the effectiveness of
programmes such as this, particularly to focus on the outcomes that most matter to the
individuals taking part and to truly reflect the actual performance, experience, and
views of the person living with dementia.
Introduction
Personalised interventions provided to people with dementia and their family carers either
separately or together can improve family carers’ well-being, delay admission to care homes,
and reduce the risk of institutionalisation by up to one-third [1–3]. In the Netherlands, a Com-
munity Occupational Therapy in Dementia (COTiD) intervention for people with mild to
moderate dementia and their family caregiver was developed, comprising ten 1-hour sessions
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delivered over 5 weeks in the person with dementia’s home [4]. A single-site randomised con-
trolled trial (RCT) comparing COTiD with treatment as usual (TAU) demonstrated benefits to
activities of daily living (ADL) for people with dementia and improved sense of competence in
family carers [5]. The secondary outcomes, quality of life, and mood for people with dementia
and their family carers also improved [6], and COTiD was cost-effective [7]. In contrast, a sub-
sequent multisite RCT of COTiD in Germany found no difference in ADL performance
between providing COTiD or a single consultation visit by an occupational therapist [8]. The
integral process evaluation highlighted the need to not only translate but also to adapt complex
interventions to the local context for evaluation and cross-national comparison to be effective
[9]. These contrasting findings showed the need for a large multisite RCT of COTiD compared
with usual care before it could be adopted into practice in the United Kingdom. We therefore
translated the COTiD intervention and adapted it to make it more suitable for the UK using a
range of activities. We trained 44 occupational therapists who put COTiD into practice with
130 pairs; ran focus groups and a consensus event; and conducted a national online survey to
scope current UK occupational therapy practice and service provision for people with mild to
moderate dementia and their family carers living in the community [10–11]. Our adaptations
included the following: retaining the 10 hours of intervention but extending the length of
delivery to 10 weeks, with individual session length being flexible so as to maximise the
achievement of the goals set (for example, to accommodate activities being completed in the
community that may take longer than 1 hour) and using a wider range of validated assessment
tools in line with usual UK practice. This produced the “Community Occupational Therapy in
Dementia–UK version” (COTiD-UK) in readiness for evaluation through an RCT, as part of a
funded programme of research “Valuing Active Life in Dementia” (VALID).
Our aim was to estimate the clinical and cost-effectiveness of COTiD-UK relative to TAU.
We hypothesised that, in comparison with TAU, COTiD-UK would improve personal care
and instrumental ADL performance in people with mild to moderate dementia measured
using the Bristol Activities of Daily Living Scale (BADLS) score at 26 weeks as our primary
outcome, as well as sense of competence and mood in family carers, and cognition, mood, and
quality of life for people with dementia and their family carers as secondary outcomes.
Methods
This study is reported according to the Consolidated Standards of Reporting Trials (CON-
SORT) Statement [12]. The CONSORT flowchart is included, and the completed CONSORT
checklist is included (S1 CONSORT Checklist).
Study design
We conducted a multicentre, pragmatic, 2-arm, parallel group, single-blind, individually ran-
domised RCT, with an internal pilot and nested economic evaluation and qualitative and fidel-
ity studies. We have previously published the full study protocol [13]. The economic
evaluation and qualitative and fidelity studies are or will be reported separately [14–15].
Participants
We recruited pairs comprising a person with dementia and their family carer. The former had
to live in their own home; have a diagnosis of dementia as defined by the DSM-IV [16]; and
score between 0.5 and 2 on the Clinical Dementia Rating Scale indicating mild to moderate
dementia [17]. Carers had to be aged 18 or over; and provide practical support with domestic
or personal activities to the person with dementia for at least 4 hours per week. Both parties
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had to be able to converse in English; be willing to participate in the COTiD-UK intervention
together if allocated to receive it; and have the capacity to provide consent.
Recruitment
Sites and occupational therapists. We invited a range of inner city, urban, and rural sites
to participate through professional and research networks, including the UK National Institute
for Health Research (NIHR) Clinical Research Network (CRN). To take part, organisations
had to provide services to people with mild to moderate dementia living in the community
and employ occupational therapists who could receive training and then deliver the COTi-
D-UK intervention. Potential sites completed a feasibility checklist to confirm that they had
these resources.
People with dementia and their carers. We approached people with dementia and their
carers through NHS clinical services, mainly memory services, and voluntary and charitable
bodies providing information and support to people with dementia and their families. We
included the study on the Join Dementia Research portal, an online resource that enables peo-
ple to register their interest in taking part in dementia research and thereby be contacted by
relevant study teams (https://www.joindementiaresearch.nihr.ac.uk/). Site-based research staff
then contacted interested people, usually by telephone, provided Participant Information
Sheets, and followed a defined screening procedure to check eligibility formally. If pairs were
eligible and wanted to take part, research staff completed study enrolment by visiting the
home of the person with dementia to seek informed consent from both the person with
dementia and their family carer.
Ethical approval
The study was approved by the NHS NRES Committee London–Camberwell St Giles (refer-
ence number 14/LO/0736) in June 2014 and local NHS research and development depart-
ments at each participating site. Written informed consent was received from all participants,
both people with dementia and their family carers.
Randomisation and masking
We allocated pairs between COTiD-UK and TAU using a remote online randomisation sys-
tem, stratified by site using random permuted blocks (block sizes of 2, 4, 7, and 14) with study
staff masked to block size. An unmasked team member at each site conducted the randomisa-
tion, informed pairs of their allocation by letter, and passed their details to the occupational
therapist to initiate contact and the intervention.
We masked the following to participants’ allocation: all research staff collecting outcome
measures; the Chief Investigator, statisticians, health economists, and other collaborators; and
the independent Programme Steering Committee (PSC), and Data Monitoring and Ethics
Committee (DMEC). It was not possible, nor desirable in a pragmatic trial, to mask the pairs,
or the occupational therapists providing the intervention. Precautions to minimise the risk of
unmasking, particularly research staff collecting follow-up data, included the following: asking
participants not to tell research staff whether or not they had received COTiD-UK; minimising
contact between masked staff and occupational therapists; and giving all research staff individ-
ual identifiers that provided access only to the necessary sections of the web-based database
[18]. We assessed the extent to which research staff had maintained masking by asking them
to state after each follow-up visit whether they had been told or inferred the pair’s allocation.
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Procedures
Interventions
Community Occupational Therapy in Dementia–UK version (COTiD-UK). COTi-
D-UK consists of up to 10 hours of community occupational therapy delivered to a person
with mild to moderate dementia and their family carer as a pair over 10 weeks. The 10 hours is
provided flexibly in response to the pair’s availability and to maximise achieving their goals
rather than being a set number of sessions. In the first phase, the occupational therapist con-
ducts a one-to-one narrative interview with the 2 participants separately; assesses the home
environment; and observes the person with dementia completing a familiar activity of their
own choice. The next phase is goal setting, when the occupational therapist summarises the
information collected and facilitates a discussion with the pair to enable them to identify,
agree, and prioritise individual and joint lifestyle goals. During the intervention phase, the
therapist supports the pair to enact their goals and coaches the carer to develop problem-solv-
ing skills and coping strategies. The sessions usually take place where the person with dementia
lives but depending on the activities chosen, may also happen in the local community, for
example, the sports club, cinema, or garden centre. At the final session, the pair and therapist
evaluate their success in achieving their goals and plan their future lifestyle accordingly.
Occupational therapists attended 2 consecutive training days and a later follow-up day,
delivered by a COTiD-UK trainer—an occupational therapist researcher with experience of
developing or delivering COTiD-UK. They then delivered COTiD-UK to a pair recruited
solely for training. Therapists audio-recorded these training sessions, as a basis for one-to-one
feedback from a COTiD-UK trainer who used a predefined checklist to assess their compe-
tency to deliver the intervention in accordance with the study protocol. Participating therapists
received monthly supervision throughout their involvement. The COTiD-UK supervisors met
monthly by telephone with a COTiD-UK trainer to monitor progress.
Participating therapists audio-recorded all sessions as practicable, to enable researchers to
monitor intervention fidelity through a nested longitudinal observational study [15]. We purpo-
sively sampled 10% of recorded sessions to include a range of sites and level of therapist experi-
ence in delivering COTiD-UK and then transcribed and coded them using fidelity checklists.
We defined adherence to COTiD-UK as completing the goal-setting phase and monitored
this using a COTiD-UK Checklist that was developed for the study and completed by the occu-
pational therapists for each pair. The research team and COTiD-UK trainers agreed that this
criterion indicated delivery of the initial core elements of the intervention.
Treatment as usual (TAU). TAU comprises the usual service provided locally, which
could have included standard occupational therapy. As services available to people with
dementia and their carers varied between and within sites, each site completed a template
detailing usual treatment. To reduce contamination between the 2 groups, we asked occupa-
tional therapists trained to deliver COTiD-UK not to provide occupational therapy to trial
pairs allocated to TAU nor to share their COTiD-UK training or materials with occupational
therapists not so trained. Such limitations on sharing were feasible because COTiD-UK differs
in content and duration from current UK occupational therapy practice [11]. At each site, an
unmasked researcher monitored contamination by checking whether TAU pairs reported con-
tact with COTiD-UK trained occupational therapists.
Data collection
We collected the complete dataset through interviews in participants’ homes at baseline, 12
and 26 weeks. We collected a reduced dataset from the carer by telephone at 52 and 78 weeks
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after randomisation. We planned to follow-up all pairs at 52 weeks and for the first 40% of
pairs recruited to the trial at 78 weeks. However, due to delays in recruiting the research sites
and then the pairs, alongside the need to complete the trial on time as agreed with the study
funder, in practice this was not feasible and was revised.
Outcomes
The primary outcome measure was total score on the BADLS at 26 weeks [19]. BADLS is a
carer-rated scale of ADL performance of 20 personal care and instrumental activities, with
higher scores indicating higher dependence. It is valid, reliable, and responsive to change over
time [20].
Secondary outcome measures for the person with dementia included cognition (Mini Men-
tal State Examination, MMSE) [21]; quality of life (Dementia Quality of Life Scale, DEMQOL)
[22]; assistance needed with ADL (Interview of Deterioration in Daily activities in Dementia,
IDDD) [23]; and mood (Cornell Scale for Depression in Dementia, CSDD) [24]. Carer second-
ary outcomes were sense of competence (Sense of Competence Questionnaire, SCQ) [25] and
mood (Hospital Anxiety and Depression Scale, HADS) [26]. We collected the number of social
contacts and leisure activities over the previous 12 weeks as a measure of social functioning for
both types of participants. For the intervention group only, occupational therapists used the
COTiD-UK Checklist to record the number, duration, and content of sessions delivered; the
number of goals set; and the number fully or partially achieved.
Serious adverse events
In accordance with Good Clinical Practice, we recorded deaths and serious adverse events
(SAEs), namely those that were life threatening, required or extended hospitalisation, resulted
in disability or incapacity, or were otherwise considered significant, as well as vulnerable adult
protection alerts.
Statistical analysis
Sample size. We based the target sample size on a standardised mean difference of 0.35
between the COTiD-UK and control groups for the primary outcome of total BADLS score at
week 26. The effect size of 0.35 was determined using the clinical expertise of the applicant
group and based on the DOMINO group consensus advice regarding the minimum clinically
important difference (MCID) using the BADLS [27]. As such, we took a more conservative
approach than the findings of Graff and colleagues who demonstrated an effect size of 1.25,
albeit in a single-site trial with the intervention delivered by 2 therapists and using a different
outcome measure [5].
To detect this, difference with 90% power and a 5% significance level using a 2-sample t test
needed 172 pairs in each group, as estimated using STATA version 11 (StataCorp, Texas,
United States of America). The total sample size (for both groups) was inflated to allow for
15% attrition and 5% nonadherence at week 26. Additionally, we increased the size of the
intervention group to account for within-therapist clustering, assuming an intraclass correla-
tion coefficient (ICC) of 0.015 and an average of 10 pairs per therapist. In total, we planned to
recruit 256 pairs to the intervention group and 224 pairs to the TAU group.
Statistical methods. We conducted the statistical analysis according to a prespecified plan
(S1 Statistical Analysis Plan). We used a linear mixed effects model to compare the COTiD-UK
and TAU groups on the total BADLS score at week 26 adjusting for site and baseline total
BADLS score (as fixed effects); we included a random effect to account for clustering by occu-
pational therapist in the COTiD-UK arm and estimated separate variance parameters for the
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pair-level error terms in COTiD-UK and TAU arms, owing to the more flexible nature of this
model compared to that where a common variance parameter would be assumed for both
arms.
For continuous secondary outcomes, we fitted similar models, adjusting for baseline values
of the outcome, site, and a random effect to account for clustering by occupational therapist.
We used negative binomial regression models to analyse numbers of social contacts and leisure
activities. We included only participants for whom total BADLS scores were available at both
baseline and week 26 in these regression analyses.
We conducted 3 supportive analyses for the primary outcome. First, we analysed the
within-pair mean BADLS score at week 26, i.e., the within-pair sample mean score for com-
plete answers on the BADLS questionnaire, to account for missing items. Secondly, we ana-
lysed total BADLS score at week 26, adjusted for baseline predictors of missing data. We
identified predictors of missing data using logistic regression models; variables that were sig-
nificant (p-value < 0.05) were included as predictors of missing data. Thirdly, we estimated
the complier average causal effect of COTiD-UK on total BADLS score at week 26, using a
2-stage least squares approach to account for pairs who did not adhere with COTiD-UK in
that they did not complete the goal-setting phase; however, it was not possible to account for
clustering by occupational therapist in this model.
We estimated the longer-term intervention effect of COTiD-UK using a mixed effects
regression model with time as an explanatory variable and using repeated measures of BADLS
at weeks 26, 52, and 78, and similar models for the HADS anxiety and depression scores also
recorded at weeks 52 and 78. All these analyses were performed on participants as randomised
using STATA version 15.
Trial management
The NIHR appointed an independent DMEC to oversee the trial conduct and the safety of par-
ticipants. This committee received Open and Closed reports with the latter remaining confi-
dential to the Trial Manager and independent DMEC members and was not available to the
Trial Statistician who attended a portion of each meeting. Baseline, reason for withdrawal, and
SAE data were provided by group allocated in the Closed report. All data in both reports were
anonymised, and no outcome data were included. The DMEC reported to the independent
PSC, also appointed by the NIHR. North East London NHS Foundation Trust (NELFT) was
the study sponsor and carried out the necessary oversight and monitoring to ensure the study
was conducted in line with all mandatory governance requirements.
We registered the trial with Current Controlled Trials as ISRCTN10748953.
The internal pilot ran from September 2014 to April 2015 in 3 sites. We reviewed the proce-
dures and dataset against a predefined Acceptance Checklist for Clinical Effectiveness Pilot
Trial (ACCEPT) and presented this to the PSC in April 2015 [28]. The clinical researcher
responsible for training and supervising the occupational therapists delivering the intervention
was unmasked to allocation and so reviewed the SAEs reported to ensure participant safety
and the COTiD-UK Checklist data to check accuracy and to monitor intervention fidelity,
while all other data were reviewed by masked team members. No individual participant data
were presented to the PSC. Participant recruitment had been slower than expected but was
picking up, and we had achieved 88% retention at 12 weeks at the first site. We therefore
decided that we needed to recruit more sites and occupational therapists than originally
planned in order to enable us to recruit the required sample to time and target. During the
pilot, we completed the Canadian Occupational Performance Measure (COPM) [29] but
decided to omit this from the main trial, partly because we felt we needed to reduce the time
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needed for data collection to lessen the burden on participants, partly due to the feedback
from research staff about the difficulties experienced in administering this assessment in a con-
sistent and reliable way over time and between assessors, and partly due to our concern that its
completion involved participants setting activity goals that constituted an element of the
COTiD-UK intervention which made it unsuitable for use with the TAU group. Other than
this change, we confirmed that the design and methods were feasible, and the PSC supported
the internal pilot data being included within the full trial dataset. The results we present here
are therefore derived from the dataset collected during the internal pilot and full RCT.
Results
We recruited 15 sites between 22 September 2014 and 17 May 2017. One site did not proceed
to recruiting pairs due to a major service reorganisation resulting in the occupational thera-
pists we had trained not being available to take part. We recruited pairs of participants within
the other 14 sites between 30 September 2014 and 3 July 2017; the final follow-up assessment
was on 23 January 2018 when the study shut to recruitment. We trained 44 occupational thera-
pists to deliver COTiD-UK, of whom 32 proceeded to the RCT and were allocated at least 1
pair each, although 1 was subsequently unavailable to provide the intervention as planned due
to ill health.
Fig 1 shows the flow of pairs through the trial.
Fig 1. Participant flowchart. COTiD-UK, Community Occupational Therapy in Dementia–UK version; PwD, person
with dementia; TAU, treatment as usual.
https://doi.org/10.1371/journal.pmed.1003433.g001
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We allocated 468 pairs at random: 249 to COTiD-UK and 219 to TAU. Baseline characteris-
tics were very similar between the 2 groups (Table 1). People with dementia ranged in age
from 55 to 97 with a mean of 78.6 years, and family carers ranged in age from 29 to 94 with a
mean of 69.1 years. Of the people with dementia, 3 quarters were married (350/468, 74.8%),
and approximately one-fifth (90/468, 19.2%) lived alone. Approximately 3 quarters of the fam-
ily carers were spouses, and the majority of the remainder were adult children.
We collected outcome data for 400 pairs (85.5% of the original sample) at 12 weeks (COTi-
D-UK n = 216; TAU n = 184) and then for 368 (78.6% of sample) at 26 weeks (COTiD-UK
n = 207; TAU n = 161). At 26 weeks, 406 pairs (86.7% of sample: COTiD-UK n = 221; TAU
n = 185) remained in the trial. Of these, we analysed total BADLS score, the primary outcome,
for 364 pairs (77.8% of sample) (206 in the COTiD-UK group and 158 in the control group)
after excluding 4 pairs for whom a total BADLS score at baseline was missing.
At 52 weeks, we followed up 292 pairs (62.4% of sample) and of these, collected and ana-
lysed total BADLS outcome data for 239 pairs (51.1% of sample: COTiD-UK n = 137; TAU
n = 102). At 78 weeks, we followed up 150 pairs (32.1% of sample) and of these, collected and
analysed total BADLS outcome data for 113 pairs (24.1% of the original sample: COTiD-UK
n = 67; TAU n = 46). Total BADLS scores at 26 weeks did not differ at the 5% level between
the randomised groups: The adjusted mean difference estimate was 0.35 (95% CI −0.81 to
+1.51; p = 0.55). Though staff collecting outcome data could deduce the allocated treatment
for 45 (13%) of the 338 assessments, there is no evidence that this influenced scores. The
adjusted (for baseline total BADLS total and randomised group) ICC for the primary outcome
at 26 weeks was 0.043.
Results from the supportive analyses were consistent with those for the primary outcome
analysis. When considering within-pair mean BADLS score, the mean difference estimate was
0.02 (95% CI −0.04 to +0.07). Predictors of missingness were identified as ethnicity of the per-
son with dementia (white, other, or unspecified) and marital status of the family carer (mar-
ried, widowed, or other). When adjusting for these predictors, the mean difference estimate in
total BADLS scores was 0.34 (95% CI −0.82 to +1.49). The estimated complier average causal
effect of COTiD-UK at 26 weeks was 0.42 (95% CI −0.77 to +1.60).
Secondary outcomes were also similar between the groups at 26 weeks (Table 2). For con-
tinuous outcomes, all estimated effects were close to 0. For leisure and social contacts, intensity
rate ratio estimates were close to 1.
Fig 2 and Table 3 show total BADLS scores at 52 and 72 weeks by randomised groups. Total
BADLS scores did not differ significantly between groups across time points in an adjusted
longitudinal analysis: The adjusted mean difference estimate was 0.49 (95% CI −0.47 to +1.45).
Similarly, the HADS anxiety and depression scores did not differ between groups at weeks 52
and 78 (Figs 3 and 4).
Between baseline and 26 weeks researchers and therapists recorded 131 SAEs, but did not
attribute any in the intervention group to COTiD-UK participation or any in the TAU group
to its absence.
Of the 249 pairs allocated to COTiD-UK, 22 (9%) did not reach the goal-setting phase.
Excluding 3 deaths and 8 withdrawals, the nonadherence rate was 4.6%, very close to our prior
estimate of 5%. We assessed intervention fidelity as being moderate, albeit with variation
between sites and therapists [15]. We were successful in avoiding occupational therapists
trained in COTiD-UK from providing any intervention to TAU participants. Of the 227
adherent pairs, 2 did not set any goals, and the remainder set a mean of 4.09 goals (range 1 to
13). Of the 920 goals set, 729 (79.2%) were fully achieved, and a further 107 (11.6%) were par-
tially achieved, making a total of 90.8% goals fully or partially achieved. In the main, pairs set
goals related to resuming or continuing with meaningful activities, developing strategies to
PLOS MEDICINE Community Occupational Therapy for people with dementia and their family carers
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Table 1. Participant characteristics at baseline by allocated group.










Male 154 (62%) 113 (52%) 58 (23%) 71 (32%)
Female 95 (38%) 106 (48%) 191 (77%) 148 (68%)









White British 227 (91%) 200 (91%) 228 (92%) 202 (92%)
White other 8 (3%) 10 (5%) 4 (2%) 7 (3%)
Afro Caribbean 6 (2%) 6 (3%) 9 (4%) 6 (3%)
South Asian 5 (2%) 1 (0.5%) 5 (2%) 1 (0.5%)
Other or no response 3 (1%) 2 (1%) 3 (1%) 3 (1%)
Marital status
Married 191 (77%) 159 (73%) 208 (83%) 185 (84%)
Widow(er) 46 (18%) 46 (21%) 8 (3%) 3 (1%)
Other 12 (5%) 14 (6%) 33 (13%) 31 (14%)
Carer’s relationship to person with dementia
Spouse or partner - - 189 (76%) 151 (69%)
Son or daughter - - 47 (19%) 57 (26%)
Other - - 13 (5%) 11 (5%)
Living situation of person with dementia
Living alone 44 (18%) 46 (21%) - -
Living with spouse or partner 190 (76%) 162 (74%) - -
Living with others 15 (6%) 11 (5%) - -
Dementia diagnosis
Alzheimer’s disease 132 (53%) 115 (52%) - -
Vascular dementia 47 (19%) 45 (21%) - -
Mixed 30 (12%) 30 (14%) - -
Other or not known 40 (16%) 29 (13%) - -
Clinical Dementia Rating
0.5 82 (33%) 74 (34%) - -
1.0 135 (54%) 115 (53%) - -
2.0 32 (13%) 28 (13%) - -
BADLS n = 248 n = 215 - -
13.6 (9.0) 14.7 (9.7)
MMSE n = 249 n = 219 - -
20.7 (5.3) 21.4 (4.8)
IDDD n = 249 n = 218 - -
45.9 (10.5) 46.9 (11.6)
DEMQOL n = 234 n = 212 - -
92.1 (12.7) 90.8 (12.4)
DEMQOL proxy n = 238 n = 204 - -
93.4 (12.5) 93.1 (13.9)
CSDD n = 246 n = 216 - -
4.3 (4.2) 4.5 (3.8)
SCQ - - n = 240 n = 213
94.6 (17.6) 93.8 (15.8)
(Continued)
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enable living with dementia, and connecting with their local community and potential sources
of support. The goals that were partially or not achieved were frequently dependent on other
services or community resources for completion so if these were not available or able to
respond within the timeframe of the intervention, for example, a community group that met
infrequently, some goals were still pending at the time of the evaluation.
Table 1. (Continued)









HADS—anxiety - - n = 248 n = 217
6.6 (4.5) 6.8 (4.4)
HADS—depression - - n = 249 n = 217
4.2 (3.5) 4.3 (3.3)
Social contacts n = 245 n = 216 n = 246 n = 217
38.1 (29.7) 40.9 (38.8) 41.7 (50.7) 41.9 (34.9)
Leisure activities n = 246 n = 218 n = 247 n = 218
31.7 (38.4) 33.8 (43.1) 39.2 (45.8) 37.9 (43.0)
BADLS, Bristol Activities of Daily Living Scale; COTiD-UK, Community Occupational Therapy in Dementia–UK version; CSDD, Cornell Scale for Depression in
Dementia; DEMQOL, Dementia Quality of Life Scale; HADS, Hospital Anxiety and Depression Scale; IDDD, Interview of Deterioration in Daily activities in Dementia;
MMSE, Mini Mental State Examination; SCQ, Sense of Competence Questionnaire; TAU, treatment as usual.
https://doi.org/10.1371/journal.pmed.1003433.t001
Table 2. Outcomes at 26 weeks for people with dementia and family carers by allocated group.
Means (standard deviations)
Measure (n = COTiD-UK / TAU groups) COTiD-UK TAU Adjusted� mean difference (95% CI)
People with dementia
BADLS (n = 207 / 161) 15.4 (9.6) 16.5 (10.7) 0.35 (−0.81, 1.51); p = 0.55
MMSE (192 / 145) 20.4 (6.1) 20.9 (5.4) 0.35 (−0.40, 1.11)
IDDD
(194 / 150)
47.2 (12.8) 47.7 (12.7) 0.03 (−1.89, 1.96)
DEMQOL (n = 183 / 140) 93.6 (11.7) 92.6 (11.7) 0.51 (−1.36, 2.38)
DEMQOL proxy (n = 182 / 141) 93.6 (14.5) 92.4 (13.6) 0.70 (−1.32, 2.72)
CSDD (n = 190 / 144) 3.4 (4.0) 3.6 (4.2) −0.002 (−0.77, 0.77)
Family carer
SCQ (n = 180 / 140) 95.6 (18.3) 95.0 (15.7) −0.09 (−2.52, 2.35)
HADS—anxiety (n = 192 / 151) 6.6 (4.4) 6.3 (4.1) 0.39 (−0.16, 0.93)





PwD social contacts (n = 196 / 152) 39.9 (38.5) 42.3 (42.7) 0.99 (0.83, 1.18)
FC social contacts (n = 195 / 152) 39.5 (33.7) 39.0 (38.2) 1.17 (0.98, 1.41)
PwD leisure activities (n = 196 / 152) 37.8 (40.6) 36.2 (41.7) 1.01 (0.79, 1.29)
FC leisure activities (n = 195 / 151) 36.8 (42.5) 36.7 (37.1) 1.03 (0.82, 1.28)
�Adjusted for baseline value, site, and occupational therapist clustering in the COTiD-UK arm.
��Adjusted for baseline value and site.
BADLS, Bristol Activities of Daily Living Scale; COTiD-UK, Community Occupational Therapy in Dementia–UK version; CSDD, Cornell Scale for Depression in
Dementia; DEMQOL, Dementia Quality of Life Scale; FC, family carer; HADS, Hospital Anxiety and Depression Scale; IDDD, Interview of Deterioration in Daily
activities in Dementia; MMSE, Mini Mental State Examination; PwD, person with dementia; SCQ, Sense of Competence Questionnaire; TAU, treatment as usual.
https://doi.org/10.1371/journal.pmed.1003433.t002
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Discussion
To our knowledge, this was the biggest RCT of occupational therapy for people with mild to
moderate dementia and their family carers to date in the UK, conducted in 15 sites across
England. We recruited 468 pairs who were randomly allocated to either the COTiD-UK (249)
or TAU (219) group. We observed no statistically significant difference between the COTi-
D-UK and TAU groups for the primary outcome, total BADLS score at 26 weeks, or the sec-
ondary outcome measures, at any of the 4 follow-up points. Although there were no
significant differences in the validated outcome measures, there was a very high rate of goal
attainment in the intervention group. Admittedly, we were not able to compare these rates
with the TAU group who had not set goals, since goal setting was a key component of the
COTiD-UK intervention and could therefore not realistically be completed with the TAU
group.
Our results therefore accord with those of the trial of COTiD conducted in Germany [8]
but not the Netherlands [5–6]. Usual care differed greatly between the Netherlands and the
UK, which may have had an impact on the results. When the Dutch study was conducted,
community occupational therapy for people with dementia in the Netherlands was in its
infancy. Since the VALID research programme began in 2012, UK memory services have
Fig 2. Total BADLS score: means and 95% CIs over time by allocated group. BADLS, Bristol Activities of Daily
Living Scale; COTiD-UK, Community Occupational Therapy in Dementia–UK version; TAU, treatment as usual.
https://doi.org/10.1371/journal.pmed.1003433.g002
Table 3. Outcomes at 52 and 78 weeks for people with dementia and family carers by allocated group.
Means (SDs) 52 weeks 78 weeks



























BADLS, Bristol Activities of Daily Living Scale; COTiD-UK, Community Occupational Therapy in Dementia–UK version; HADS, Hospital Anxiety and Depression
Scale; TAU, treatment as usual.
https://doi.org/10.1371/journal.pmed.1003433.t003
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become well established, and the policy emphasis for earlier diagnosis and access to services
means more people may receive occupational therapy input during the mild to moderate stage
of dementia, although this is usually less than the COTiD-UK intervention and focused on just
the person with dementia’s needs rather than being dyadic in nature [11]. Some potential par-
ticipants declined to take part in the study as the family carers stated they were “managing
fine” and therefore did not see the need for intervention [30]. Having said that, 227 of the 249
pairs allocated to take part in the intervention did set goals, of which 91% were fully or partially
achieved.
This study had several strengths. Firstly, this was an RCT that achieved 97.5% of the target
recruitment sample, as well as low attrition and nonadherence rates, with no evidence of con-
tamination between the 2 groups. Intervention fidelity was moderate suggesting that the par-
ticipants received the sessions as planned, although there was variation between sites and
between occupational therapists. This was lower than that reported by Graff and colleagues in
a single-site trial that involved only 2 therapists who were deeply committed and closely
Fig 3. HADS anxiety score: means and 95% CIs over time by allocated group. COTiD-UK, Community
Occupational Therapy in Dementia–UK version; HADS, Hospital Anxiety and Depression Scale; TAU, treatment as
usual.
https://doi.org/10.1371/journal.pmed.1003433.g003
Fig 4. HADS depression score: means and 95% CIs over time by allocated group. COTiD-UK, Community
Occupational Therapy in Dementia–UK version; HADS, Hospital Anxiety and Depression Scale; TAU, treatment as
usual.
https://doi.org/10.1371/journal.pmed.1003433.g004
PLOS MEDICINE Community Occupational Therapy for people with dementia and their family carers
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1003433 January 4, 2021 14 / 19
monitored [5]. In contrast, our trial was much larger involving 32 occupational therapists
across England, whose level of prior dementia and specific COTiD-UK experience varied. In
addition, this pragmatic trial of COTiD-UK was conducted across 15 sites and against a range
of organisational issues that inevitably had an impact on the delivery of the intervention by the
occupational therapists who relied on their managers and colleagues’ support to implement
this new intervention, often alongside their usual practice. As reported earlier, 1 site was
unable to progress to actually recruit pairs due to service reorganisation that resulted in the
occupational therapists we had trained no longer being available.
There were also several limitations. Overall, the sample was representative of the target pop-
ulation, i.e., people with mild to moderate dementia and their family carers living in the com-
munity, excepting for ethnicity. The eligibility criteria of needing to speak English obviously
affected recruitment of participants from non-English-speaking populations and is not
unusual [31]. However, this was essential to enable data collection to be completed and the
intervention to be provided on the basis of all providers and participants sharing similar levels
of first language skills.
There was often an issue of recall for people with dementia. Hence, the majority of outcome
data relating to the person with dementia were collected by proxy and may not reflect the
actual performance, experience, and views of the person with dementia. An observational
ADL measure, such as the Assessment of Motor and Process Skills [32] which Graff and col-
leagues [5] used might have provided more accurate data about the person with dementia’s
performance. However, this has to be administered by an occupational therapist who has
undergone additional training and achieved calibration. As the percentage of AMPS trained
occupational therapists is far lower in the UK than in the Netherlands, this multisite study was
not able to adopt this measure due to the resource implications as noted previously [33]. Many
participants, both people with dementia and family carers, also found it difficult to recall what
leisure and social activities they had done over the preceding 12 weeks and, although it had
originally been planned to ask participants to complete a diary tool, evidence indicates that
these are rarely completed accurately, and so this plan was dropped. Hence, the accuracy of
these data is questionable [34]. Despite the Graff study [5] showing improvement, at least in
the short term, there are inherent difficulties in expecting improvements in ADL in someone
with a progressive condition such as dementia. Measuring the impact on cognition, ADL, and
quality of life was established as a feature of pharmacological trials that has subsequently been
adopted when evaluating psychosocial interventions. Perhaps maintenance rather than
improved performance would be a more realistic measure of effectiveness. We also noted that
in the main, pairs set goals related to a wider range of activities than those covered within a tra-
ditional ADL assessment such as the BADLS, for example, leisure, creative, and social activi-
ties. The outcome tools primarily measured level of impairment, but there is now increasing
emphasis within dementia research on the importance of measuring potentially positive out-
comes rather than just simply the negative consequences of dementia, such as cognitive
impairment and functional decline. A number of positive psychology measures have now been
developed, which may help us to better understand how people’s capabilities and self-manage-
ment skills might be enhanced through training and goal setting [35]. Furthermore, a develop-
ing research agenda is focused on developing patient-related outcome measures (PROMs) in
formats that make them suitable for self-report. This would enable data to be collected directly
from people with dementia themselves to reflect their own views in preference to the tradi-
tional reliance on proxy measurement via their carers who obviously provide their own point
of view.
There is a need for innovation and improvement in dementia care in all health systems, and
this study shows that it is feasible to conduct rigorous clinical trials of complex interventions
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by practitioners across many sites. Our occupational therapists recognised the relevance of the
intervention to their practice and showed commitment and persistence in delivering the trial.
We found no statistical evidence of clinical benefits for COTiD-UK as delivered in this
study. The intervention delivery achieved moderate fidelity, suggesting that people with
dementia and family carers received it as planned in terms of its aim and purpose. Trials of
psychosocial dementia interventions are still in their infancy so much can be learnt from this
study. With both the COTiD-UK and the German COTiD trials not finding significant bene-
fits, it is not clear how far COTiD should be further evaluated using this kind of design, hence
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